Ilias P.
- Country
- Greece
- Department
- Pulmonary Department
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- A Phase 2a Study to Evaluate the Safety and Efficacy of ABBV-142 in Adults with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 104 of 215 partner sites.
Specializations
Respiratory Diseases
This investigator specializes in treating complex respiratory conditions, with particular emphasis on pulmonary sarcoidosis and its various manifestations. Their research explores innovative therapeutic approaches for managing granulomatous inflammation in the lungs.
- Active Pulmonary Sarcoidosis
- Extrapulmonary Manifestations
- Granulomatous Inflammation
Their work includes evaluation of novel treatments for reducing inflammation in pulmonary parenchyma.
Infectious Respiratory Conditions
The investigator focuses on treating community-acquired pneumonia and its complications, particularly investigating preventive approaches against sepsis progression. Their research includes biomarker-guided treatment strategies.
- Pneumonia Management
- Sepsis Prevention
- Biomarker-Guided Therapy
Their expertise extends to early intervention protocols in respiratory infections.
Chronic Airway Diseases
The investigator specializes in treating severe asthma, particularly cases that are inadequately controlled with standard treatments. Their work involves evaluating combination therapies for improved lung function.
- Severe Asthma Management
- Combination Inhaler Therapy
- Asthma Exacerbation Prevention
Their research focuses on optimizing treatment outcomes for patients with persistent symptoms.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.